A survival‐adjusted quantal response test for comparing tumour incidence rates
Shyamal D. Peddada,
Gregg E. Dinse and
Joseph K. Haseman
Journal of the Royal Statistical Society Series C, 2005, vol. 54, issue 1, 51-61
Abstract:
Summary. The paper presents a case‐study of skin fibromas among male rats in the 2‐year cancer bioassay of methyleugenol that was conducted by the US National Toxicology Program (NTP). In animal carcinogenicity experiments such as this one, tumour rates are often compared with the Cochran–Armitage (CA) trend test. The operating characteristics of the CA test, however, can be adversely affected by survival differences across groups and by the assumed dose metric. Survival‐adjusted generalizations of the CA test have been proposed, but they are still sensitive to the choice of scores that are assigned to the dose groups. We present an alternative test, which outperforms the survival‐adjusted CA test which is currently used by the NTP to compare incidence rates. Simulated data from a wide range of realistic situations show that the operating characteristics of the test proposed are superior to those of the NTP's survival‐adjusted CA test, especially for rare tumours and wide logarithmic spacings of the dose metric.
Date: 2005
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
https://doi.org/10.1111/j.1467-9876.2005.00469.x
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:bla:jorssc:v:54:y:2005:i:1:p:51-61
Ordering information: This journal article can be ordered from
http://ordering.onli ... 1111/(ISSN)1467-9876
Access Statistics for this article
Journal of the Royal Statistical Society Series C is currently edited by R. Chandler and P. W. F. Smith
More articles in Journal of the Royal Statistical Society Series C from Royal Statistical Society Contact information at EDIRC.
Bibliographic data for series maintained by Wiley Content Delivery ().